CMOMO: a deep multi-objective optimization framework for constrained molecular multi-property optimization
Briefings in Bioinformatics · 02.07.2025 · 26 (4)
DOI: 10.1093/bib/bbaf335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 10.07.2025. Verfasst von Xin Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Jiul…. Hauptthemen laut MEDLINE: Drug Discovery, Computational Biology, Drug Development. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Molecular optimization, aiming to identify molecules with improved properties from a huge chemical search space, is a critical step in drug development. This task is challenging due to the need to optimize multiple properties while adhering to stringent drug-like criteria. Recently, numerous effective artificial intelligence methods have been proposed for molecular optimization. However, most of them neglect the constraints in molecular optimization, thereby limiting the development of high-quality molecules that simultaneously satisfy property objectives and constraint compliance. To address this issue, we proposed a deep multi-objective optimization framework, termed CMOMO, for constrained molecular multi-property optimization. The proposed CMOMO divides the optimization process into two stages, which enables it to use a dynamic constraint handling strategy to balance multi-property optimization and constraint satisfaction. Besides, a latent vector fragmentation based evolutionary reproduction strategy is designed to generate promising molecules effectively. Experimental results on two benchmark tasks show that the proposed CMOMO outperforms five state-of-the-art methods to obtain more successfully optimized molecules with multiple desired properties and satisfying drug-like constraints. Moreover, the superiority of CMOMO is verified on two practical tasks, including a potential protein-ligand optimization task of 4LDE protein, which is the structure of $\beta $2-adrenoceptor GPCR receptor, and a potential inhibitor optimization task of glycogen synthase kinase-3$\beta $ target (GSK3$\beta $). Notably, CMOMO demonstrates a two-fold improvement in success rate for the GSK3$\beta $ optimization task, successfully identifying molecules with favorable bioactivity, drug-likeness, synthetic accessibility, and adherence to structural constraints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Artificial Intelligence, Anhui University, Jiulong Road, Hefei 230601, China.
- The Key Laboratory of Intelligent Computing and Signal Processing of Ministry of Education, School of Computer Science and Technology, Anhui University, Jiulong Road, Hefei 230601, China.
- College of Computer Science and Electronic Engineering, Hunan University, Lushan Road, Changsha 410012, China.
Zitieren
APA
Xia, X., Zhang, Y., Zeng, X., Zhang, X., Zheng, C., & Su, Y. (2025). CMOMO: a deep multi-objective optimization framework for constrained molecular multi-property optimization. Briefings in Bioinformatics, 26(4). https://doi.org/10.1093/bib/bbaf335
Vancouver
Xia X, Zhang Y, Zeng X, Zhang X, Zheng C, Su Y. CMOMO: a deep multi-objective optimization framework for constrained molecular multi-property optimization. Briefings in Bioinformatics. 2025;26(4). doi:10.1093/bib/bbaf335
BibTeX
@article{Xia2025,
author = {Xia, Xin and Zhang, Yajie and Zeng, Xiangxiang and Zhang, Xingyi and Zheng, Chunhou and Su, Yansen},
title = {CMOMO: a deep multi-objective optimization framework for constrained molecular multi-property optimization},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {4},
doi = {10.1093/bib/bbaf335}
}
EUVIMED